Want to take pharma mobile? Look to Africa's living lab approach
This article was originally published in Scrip
Executive Summary
Mobile, or m-health, is set to take a considerable slice of US medical device and pharma markets. Europe is eyeing the market, too. But to determine the adaptability of the concept in a local context, Africa provides a good case study. Sinseprod's Dr Adesina Iluyemi tells Salina Christmas about the 'living lab' strategy.